These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 37149980)

  • 1. Exploring the potential of antimalarial nanocarriers as a novel therapeutic approach.
    Deshmukh R
    J Mol Graph Model; 2023 Jul; 122():108497. PubMed ID: 37149980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promising nanomaterials in the fight against malaria.
    Neves Borgheti-Cardoso L; San Anselmo M; Lantero E; Lancelot A; Serrano JL; Hernández-Ainsa S; Fernàndez-Busquets X; Sierra T
    J Mater Chem B; 2020 Oct; 8(41):9428-9448. PubMed ID: 32955067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology applied to the treatment of malaria.
    Santos-Magalhães NS; Mosqueira VC
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):560-75. PubMed ID: 19914313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunity in nanomedicine to counter the challenges of current drug delivery approaches used for the treatment of malaria: a review.
    Rajwar TK; Pradhan D; Halder J; Rai VK; Kar B; Ghosh G; Rath G
    J Drug Target; 2023 Apr; 31(4):354-368. PubMed ID: 36604804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotherapeutics against malaria: A decade of advancements in experimental models.
    Avalos-Padilla Y; Fernàndez-Busquets X
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(2):e1943. PubMed ID: 38426407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Nanomedicines in Controlling Malaria: A Review.
    Sharma S; Rawat K; Bohidar HB
    Curr Top Med Chem; 2023; 23(16):1477-1488. PubMed ID: 37073152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyamidoamine nanoparticles as nanocarriers for the drug delivery to malaria parasite stages in the mosquito vector.
    Urbán P; Ranucci E; Fernàndez-Busquets X
    Nanomedicine (Lond); 2015 Nov; 10(22):3401-14. PubMed ID: 26582279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nano-facilitated drug delivery strategies in the treatment of plasmodium infection.
    Puttappa N; Kumar RS; Kuppusamy G; Radhakrishnan A
    Acta Trop; 2019 Jul; 195():103-114. PubMed ID: 31039335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicine against malaria.
    Urbán P; Fernàndez-Busquets X
    Curr Med Chem; 2014; 21(5):605-29. PubMed ID: 24164202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in nanomedicines for malaria treatment.
    Aditya NP; Vathsala PG; Vieira V; Murthy RS; Souto EB
    Adv Colloid Interface Sci; 2013 Dec; 201-202():1-17. PubMed ID: 24192063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptation of targeted nanocarriers to changing requirements in antimalarial drug delivery.
    Marques J; Valle-Delgado JJ; Urbán P; Baró E; Prohens R; Mayor A; Cisteró P; Delves M; Sinden RE; Grandfils C; de Paz JL; García-Salcedo JA; Fernàndez-Busquets X
    Nanomedicine; 2017 Feb; 13(2):515-525. PubMed ID: 27720930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in use of silver nanoparticles as antimalarial agents.
    Rai M; Ingle AP; Paralikar P; Gupta I; Medici S; Santos CA
    Int J Pharm; 2017 Jun; 526(1-2):254-270. PubMed ID: 28450172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of nanotechnology in drug delivery systems for respiratory diseases (Review).
    Luo MX; Hua S; Shang QY
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid nanocarriers and molecular targets for malaria chemotherapy.
    Jain K; Sood S; Gowthamarajan K
    Curr Drug Targets; 2014 Mar; 15(3):292-312. PubMed ID: 24160438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in targeting malaria with nanotechnology-based drug carriers.
    Rashidzadeh H; Tabatabaei Rezaei SJ; Adyani SM; Abazari M; Rahamooz Haghighi S; Abdollahi H; Ramazani A
    Pharm Dev Technol; 2021 Oct; 26(8):807-823. PubMed ID: 34190000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions.
    Raj R; Mongia P; Kumar Sahu S; Ram A
    Curr Drug Targets; 2016; 17(2):206-28. PubMed ID: 26201484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnology for Targeted Drug Delivery to Treat Osteoporosis.
    Kaur M; Nagpal M; Aggarwal G
    Curr Drug Targets; 2023; 24(1):2-12. PubMed ID: 36200208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphiphilic dendritic derivatives as nanocarriers for the targeted delivery of antimalarial drugs.
    Movellan J; Urbán P; Moles E; de la Fuente JM; Sierra T; Serrano JL; Fernàndez-Busquets X
    Biomaterials; 2014 Sep; 35(27):7940-50. PubMed ID: 24930847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.